Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Insilico Biotechnology
Insilico Biotechnology
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Yokogawa acquires bioprocessing digital twin expert
The company has acquired Insilico Biotechnology to build its biopharma offering
Finance
Insilico and 2-control work towards the smart biofactory
The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Manufacturing
Insilico Biotechnology moves into the US predictive twin market
Insilico Biotechnology has announced the opening of its first subsidiary in the US, located in Boston, Massachusetts
Manufacturing
Insilico and Janssen take another step towards predictive biomanufacturing
The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and at Janssen's Spring House location in the US
Manufacturing
Insilico works with university on digital twins for antibody production
The German collaboration aims to enable true online-control of critical quality attributes such as the glycosylation profile
Subscribe now